Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

48.16
+1.954.22%
Post-market: 48.160.00000.00%19:29 EDT
Volume:2.18M
Turnover:103.87M
Market Cap:12.09B
PE:15.93
High:48.17
Open:46.59
Low:46.46
Close:46.21
52wk High:49.62
52wk Low:33.76
Shares:251.00M
Float Shares:206.00M
Volume Ratio:0.53
T/O Rate:1.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.02
EPS(LYR):2.78
ROE:40.99%
ROA:22.03%
PB:6.24
PE(LYR):17.32

Loading ...

Exelixis director Mary C. Beckerle disposes 7,712 shares for $373,646.4

Reuters
·
May 09

Exelixis Director Maria C. Freire disposes 20,634 shares for $949,164

Reuters
·
May 09

Exelixis director George Poste disposes 60,000 shares for $2.74 million

Reuters
·
May 09

Exelixis to webcast investor conference fireside chats in May

Reuters
·
May 08

Exelixis Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 07

Exelixis (EXEL) Margin Expansion To 35.1% Challenges Bearish Pricing Narratives

Simply Wall St.
·
May 07

Exelixis, Inc. : H.c. Wainwright Raises Target Price to $56 From $54

THOMSON REUTERS
·
May 07

Exelixis price target raised to $50 from $49 at Morgan Stanley

TIPRANKS
·
May 07

Exelixis price target raised to $47 from $44 at Stifel

TIPRANKS
·
May 07

Stock Track | Exelixis Soars 9.32% Intraday on Analyst Upgrades and Strong Q1 Earnings

Stock Track
·
May 07

Exelixis Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
May 07

Exelixis Seen Trading Steady on Modest Drug Growth, RBC Says

MT Newswires Live
·
May 07

Stock Track | Exelixis Soars 5.99% in Pre-market on Analyst Upgrades and Strong Q1 Earnings

Stock Track
·
May 06

Goldman Sachs Remains a Buy on Exelixis (EXEL)

TIPRANKS
·
May 06

Exelixis (EXEL) Gets a Hold from Wells Fargo

TIPRANKS
·
May 06

Exelixis Kept at Hold as Cabo Momentum Offsets Pipeline Uncertainty; Price Target Raised from $49 to $50

TIPRANKS
·
May 06

Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (LMAT), Henry Schein (HSIC) and Exelixis (EXEL)

TIPRANKS
·
May 06

Margin Gains From Oncology Portfolio Might Change The Case For Investing In Exelixis (EXEL)

Simply Wall St.
·
May 06

Exelixis Price Target Raised to $55 on Cabo Strength, Buyback-Driven EPS Growth, and Zanzalintinib Upside Optionality

TIPRANKS
·
May 06

Exelixis Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 06